Quest Diagnostics Stock Jumps 38% in a Year: What's Behind the Surge?

Quest Diagnostics (DGX) has achieved impressive growth over the past year, with its shares rising 38%. It has outperformed the industry’s 7.7% rise and the S&P 500 composite’s 17.1% gain.Presently carrying a Zacks Rank #3 (Hold), the renowned clinical laboratory continues to demonstrate robust momentum in its core customer channel, supported by a growing utilization of the Advanced Diagnostics portfolio. Strategic outreach acquisitions and a strong focus on driving operational improvements further bode well ...